Cargando…
Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma
Background and Objective: Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer and has a poor prognosis. Interleukin-2 (IL2) is a cytokine that stimulates lymphocyte proliferation. However, its role in LUAD remains unclear. Methods: The UALCAN, human protein atlas (HPA), and tumor im...
Autores principales: | Hou, Yongwang, Xiang, Baoli, Yang, Zhicong, Liu, Jiangmin, Xu, Dandan, Geng, Lina, Zhan, Minghua, Xu, Yuhuan, Zhang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515527/ https://www.ncbi.nlm.nih.gov/pubmed/37731383 http://dx.doi.org/10.1177/03946320231202748 |
Ejemplares similares
-
Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer
por: Hou, Yongwang, et al.
Publicado: (2022) -
SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015) -
High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020) -
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015) -
The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)